EIR Biopharma (Withdrawn)
Note: EIR Biopharma, Inc. withdrew its plans for an IPO in a letter to the SEC on Nov. 16, 2026. The company filed its S-1 in February 2026. (Incorporated in Delaware) We are an early-stage biopharmaceutical company focused on developing therapeutics for the treatment of eye disease. Combined, our founders have more than 50 years […]
November 18, 2026 Read More